Quick Answer
Dare Bioscience, Inc. reported Net Income of -$13.40 million for fiscal year 2025.
Dare Bioscience, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$13.40M | -230.6% |
| 2024 | -$4.05M | +86.6% |
| 2023 | -$30.16M | +2.5% |
| 2022 | -$30.95M | +20.0% |
| 2021 | -$38.70M | -41.2% |
| 2020 | -$27.40M | -92.1% |
| 2019 | -$14.26M | +14.8% |
| 2018 | -$16.74M | -45.5% |
| 2017 | -$11.50M | -1610.0% |
| 2016 | -$672.7K | +98.3% |
| 2015 | -$39.59M | -69.6% |
| 2014 | -$23.34M | -36.2% |
| 2013 | -$17.14M | +22.4% |
| 2012 | -$22.10M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.56M | +24.2% | +11.3% |
| June 30, 2025 | -$4.02M | -131.1% | +8.3% |
| March 31, 2025 | -$4.38M | +35.2% | +6.9% |
| September 30, 2024 | -$4.70M | +43.3% | -136.4% |
| June 30, 2024 | $12.91M | +247.3% | +291.1% |
| March 31, 2024 | -$6.76M | +16.0% | +18.6% |
| September 30, 2023 | -$8.30M | -18.2% | +5.3% |
| June 30, 2023 | -$8.76M | -2216.5% | -8.9% |
- Dare Bioscience, Inc. showed a decrease of -230.6% in Net Income compared to the prior fiscal year.
- Over the 2012–2025 period, Dare Bioscience, Inc.’s net income has grown by 39.4% (from -$22.10 million to -$13.40 million).
- The most recent figure is from Dare Bioscience, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: